title: Clinical option of omalizumab on refractory vasospastic angina with asthma and eosinophilic chronic rhinosinusitis.
authors.affiliation: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan. Electronic address: sh1124@kuhp.kyoto-u.ac.jp.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Hamada
authors.affiliation: Department of Airway Medicine, Mitsubishi Kyoto Hospital, Nishikyo-ku, Kyoto, Japan.
authors.forename: Shuji
authors.initials: S
authors.lastname: Tatsumi
authors.affiliation: Department of Cardiology, Mitsubishi Kyoto Hospital, Nishikyo-ku, Kyoto, Japan.
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Taniguchi
authors.affiliation: Department of Airway Medicine, Mitsubishi Kyoto Hospital, Nishikyo-ku, Kyoto, Japan.
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Yasuba
mesh_terms: D000368:Aged; D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy*; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications; D002908:Chronic Disease; D004802:Eosinophilia; D005260:Female; D006801:Humans; D000069444:Omalizumab / Q000627:therapeutic use*; D012220:Rhinitis / Q000150:complications; D012852:Sinusitis / Q000150:complications
chemical_list: D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000069444:Omalizumab